- Home
- BITF vs TWST Comparison
BITF vs TWST Comparison
Compare BITF & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BITF | TWST |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BITF | TWST |
|---|---|---|
| Price | $2.64 | $45.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $3.67 | ★ $44.67 |
| AVG Volume (30 Days) | ★ 37.0M | 1.2M |
| Earning Date | 11-13-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $276,409,000.00 | ★ $376,572,000.00 |
| Revenue This Year | $47.67 | $16.69 |
| Revenue Next Year | $0.20 | $15.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 94.98 | 20.32 |
| 52 Week Low | $0.67 | $23.30 |
| 52 Week High | $6.60 | $55.33 |
Technical Indicators
Market Signals| Indicator | BITF | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 45.62 | 79.06 |
| Support Level | $2.59 | $39.13 |
| Resistance Level | $3.04 | $45.76 |
| Average True Range (ATR) | 0.20 | 2.29 |
| MACD | -0.01 | 0.80 |
| Stochastic Oscillator | 11.48 | 96.07 |
Price Performance
Historical ComparisonAbout BITF Bitfarms Ltd.
Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.